Pharmabiz

DCOIWA sets bold three-year roadmap at first executive committee meeting of 2025-28 term

DCOIWA sets bold three-year roadmap at first executive committee meeting of 2025-28 term: Peethambaran Kunnathoor, Chennai ...
Opinion
PharmabizOpinion

Govt must make budgetary provision for inclusion of Ayurveda in AB-PMJAY: Rajiv Vasudevan

Govt must make budgetary provision for inclusion of Ayurveda in AB-PMJAY: Rajiv Vasudevan: Shardul Nautiyal, Mumbai Saturday, January 17, 2026, 08:00 Hrs [IST] The Government of I ...
Pharmabiz

Ayush and herbal products export stays at $43.6 million in November, 2025

Exports of Ayush and herbal products for the month of November, 2025, stood stagnant at $43.6 million compared to $43.5 million registered in the same month of previous fiscal year. This is following ...
Pharmabiz

ViNS to boost indigenous plasma protein production with Rs. 150 crore investment in PlasmaGen

ViNS Bioproducts has made a strategic Rs. 150 crore investment in Kolar-based PlasmaGen Biosciences, underscoring its commitment to strengthening indigenous production of plasma-derived proteins in ...
Pharmabiz

MSMEs want expanded credit guarantee scheme in Union Budget to upgrade their units

MSMEs want expanded credit guarantee scheme in Union Budget to upgrade their units: Nandita Vijayasimha, Bengaluru Saturday, January 17, 2026, 08:00 Hrs [IST] The pharmaceutical s ...
Pharmabiz

Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer

Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...
Pharmabiz

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid: Our Bureau, Chennai Friday, January 16, 2026, 17:15 Hrs [IST] In a significant crackdown on the illega ...
Pharmabiz

US FDA grants Orphan Drug Designation to Adolore BioTherapeutics’ Kv7-activating rdHSV-CA8 therapy to treat erythromelalgia

US FDA grants Orphan Drug Designation to Adolore BioTherapeutics’ Kv7-activating rdHSV-CA8 therapy to treat erythromelalgia: Delray Beach, Florida Friday, January 16, 2026, 17:0 ...
Pharmabiz

Diabeloop & Sequel Med Tech ink partnership to integrate US FDA-cleared DBLG2 into the twiist AID system

Diabeloop & Sequel Med Tech ink partnership to integrate US FDA-cleared DBLG2 into the twiist AID system: Grenoble, France Friday, January 16, 2026, 16:00 Hrs [IST] Following the ...
Pharmabiz

ImmunityBio’s Anktiva receives Saudi FDA approval for non-muscle invasive bladder cancer with carcinoma in-situ

ImmunityBio’s Anktiva receives Saudi FDA approval for non-muscle invasive bladder cancer with carcinoma in-situ: Culver City, California Friday, January 16, 2026, 15:00 Hrs [IST ...
Pharmabiz

Manipal Hospital Bhubaneswar unveils surgical trust campaign on 11 years of complex interventions

Manipal Hospital Bhubaneswar unveils surgical trust campaign on 11 years of complex interventions: Our Bureau, Bengaluru Friday, January 16, 2026, 14:45 Hrs [IST] Manipal Hospital ...
Pharmabiz

Boston Scientific enters agreement to acquire Penumbra for $14.5 billion

Boston Scientific enters agreement to acquire Penumbra for $14.5 billion: Marlborough, Massachusetts Friday, January 16, 2026, 14:30 Hrs [IST] Boston Scientific Corporation and Pe ...